Cystic Fibrosis and Cognitive Function
Status
Conditions
Details and patient eligibility
About
The long-term goal of this project is to examine the effects of cystic fibrosis (CF) and cystic fibrosis related diabetes (CFRD) on brain structure and function
Full description
A growing body of evidence suggests that hyperglycemia in type 1 and type 2 diabetes is associated with alterations in brain structure and cognitive impairment. People with cystic fibrosis related diabetes (CRFD) are exposed to hyperglycemia as seen in other forms of diabetes, and cystic fibrosis is also associated with chronic systemic inflammation. Both hyperglycemia and chronic inflammation have been postulated to affect brain structure and function. Cystic fibrosis trans-membrane conductance regulator (CFTR). protein is widely expressed in the neurons of the brain including in the hippocampus The hippocampus plays an essential role in learning and memory processing and is thought to be particularly vulnerable to effects of metabolic stressors. The expression of CFTR in neurons has several potential implications for central nervous system function, including cognition.
The long-term goal of this project is to examine the effects of cystic fibrosis (CF) and cystic fibrosis related diabetes (CFRD) on brain structure and function.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
patients with Cystic fibrosis
Exclusion criteria
- History of stroke
- History of epilepsy
- History of neurosurgical procedures
- Past or current history of severe psychiatric illness
- Pass or current history of alcohol or substance abuse
- Presence of metallic substances in body or inability to remove before imaging procedure
- History of claustrophobia or known inability to tolerate MRI
- Current pregnancy
- Inability to consent
Trial design
28 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal